[Alterations of hemostasis in systemic vasculitis]

Area of Science:

• Vascular Biology
• Hematology
• Rheumatology

Context:

• Coagulation abnormalities are prevalent in primary vascular diseases and vasculitides linked to systemic connective tissue diseases.
• These conditions are characterized by a thrombotic tendency stemming from platelet activation and endothelial cell damage.
• Altered fibrinolytic activity further contributes to the hemostatic imbalance.

Purpose:

• To review and synthesize existing data on coagulation abnormalities in patients with primary vascular diseases and connective tissue diseases.
• To elucidate the mechanisms underlying the thrombotic tendency in these patient populations.
• To explore the role of proliferative events in the long-term vascular complications.

Summary:

• Patients with primary vascular diseases or vasculitides associated with systemic connective tissue diseases exhibit significant coagulation abnormalities.
• Key pathological features include platelet activation, endothelial cell injury, and modified fibrinolytic activity, leading to a prothrombotic state.
• Proliferative changes initiated by platelet activation and endothelial injury persist post-inflammation, contributing to chronic vascular lumen obstruction.

Impact:

• Highlights the persistent nature of vascular pathology beyond active inflammation in connective tissue diseases.
• Underscores the critical role of platelet and endothelial dysfunction in the pathogenesis of vascular complications.
• Provides insights for potential therapeutic strategies targeting thrombosis and vascular remodeling in these complex conditions.